25 XP   0   0   10

Formosa Laboratories Inc
Buy, Hold or Sell?

Let's analyse Formosa Laboratories Inc together

PenkeI guess you are interested in Formosa Laboratories Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Formosa Laboratories Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Formosa Laboratories Inc

I send you an email if I find something interesting about Formosa Laboratories Inc.

Quick analysis of Formosa Laboratories Inc (30 sec.)










What can you expect buying and holding a share of Formosa Laboratories Inc? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
NT$68.27
Expected worth in 1 year
NT$71.71
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
NT$3.44
Return On Investment
3.2%

For what price can you sell your share?

Current Price per Share
NT$107.50
Expected price per share
NT$96.80 - NT$121.00
How sure are you?
50%

1. Valuation of Formosa Laboratories Inc (5 min.)




Live pricePrice per Share (EOD)

NT$107.50

Intrinsic Value Per Share

NT$73.12 - NT$127.58

Total Value Per Share

NT$141.39 - NT$195.85

2. Growth of Formosa Laboratories Inc (5 min.)




Is Formosa Laboratories Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$254.5m$227.6m$22.2m8.9%

How much money is Formosa Laboratories Inc making?

Current yearPrevious yearGrowGrow %
Making money$978.3k$3.1m-$2.1m-224.3%
Net Profit Margin2.5%7.4%--

How much money comes from the company's main activities?

3. Financial Health of Formosa Laboratories Inc (5 min.)




What can you expect buying and holding a share of Formosa Laboratories Inc? (5 min.)

Welcome investor! Formosa Laboratories Inc's management wants to use your money to grow the business. In return you get a share of Formosa Laboratories Inc.

What can you expect buying and holding a share of Formosa Laboratories Inc?

First you should know what it really means to hold a share of Formosa Laboratories Inc. And how you can make/lose money.

Speculation

The Price per Share of Formosa Laboratories Inc is NT$107.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Formosa Laboratories Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Formosa Laboratories Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$68.27. Based on the TTM, the Book Value Change Per Share is NT$0.86 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Formosa Laboratories Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.050.0%0.010.0%0.030.0%0.030.0%0.020.0%
Usd Book Value Change Per Share0.040.0%0.030.0%0.010.0%0.050.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.050.0%0.010.0%0.020.0%
Usd Total Gains Per Share0.040.0%0.030.0%0.060.1%0.060.1%0.060.1%
Usd Price Per Share3.16-2.78-1.78-1.85-2.04-
Price to Earnings Ratio16.80--16.14--43.11--11.60-11.51-
Price-to-Total Gains Ratio87.85--21.36--30.92-0.31-27.40-
Price to Book Ratio1.49-1.34-0.94-1.09-1.78-
Price-to-Total Gains Ratio87.85--21.36--30.92-0.31-27.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.3325
Number of shares300
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.030.05
Usd Total Gains Per Share0.030.06
Gains per Quarter (300 shares)8.0018.42
Gains per Year (300 shares)32.0173.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103222175664
20645434113138
30968652169212
4012811869226286
5016015086282360
60192182103339434
70224214120395508
80256246137452582
90288278155508656
100320310172565730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%10.010.00.050.0%29.011.00.072.5%40.011.03.074.1%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%11.09.00.055.0%27.013.00.067.5%37.017.00.068.5%
Dividend per Share0.00.04.00.0%5.00.07.041.7%8.00.012.040.0%20.00.020.050.0%25.00.029.046.3%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%12.08.00.060.0%30.010.00.075.0%41.013.00.075.9%

Fundamentals of Formosa Laboratories Inc

About Formosa Laboratories Inc

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers worldwide. It offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, antibiotics, potassium binders, and other areas. The company also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. In addition, it is involved in chemical trading; investment; and wholesale of chemical raw materials and products, as well as commission agency activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan, Taiwan.

Fundamental data was last updated by Penke on 2024-03-26 08:27:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Formosa Laboratories Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Formosa Laboratories Inc earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Formosa Laboratories Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 15.1% means that NT$0.15 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Formosa Laboratories Inc:

  • The MRQ is 15.1%. The company is making a huge profit. +2
  • The TTM is 2.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ15.1%TTM2.5%+12.6%
TTM2.5%YOY7.4%-4.9%
TTM2.5%5Y12.2%-9.7%
5Y12.2%10Y11.3%+0.9%
1.1.2. Return on Assets

Shows how efficient Formosa Laboratories Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Formosa Laboratories Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.3% Return on Assets means that Formosa Laboratories Inc generated NT$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Formosa Laboratories Inc:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM0.2%+1.1%
TTM0.2%YOY0.7%-0.5%
TTM0.2%5Y0.9%-0.7%
5Y0.9%10Y1.0%-0.1%
1.1.3. Return on Equity

Shows how efficient Formosa Laboratories Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Formosa Laboratories Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.4% Return on Equity means Formosa Laboratories Inc generated NT$0.02 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Formosa Laboratories Inc:

  • The MRQ is 2.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM0.4%+2.0%
TTM0.4%YOY1.3%-0.9%
TTM0.4%5Y1.6%-1.2%
5Y1.6%10Y1.8%-0.2%

1.2. Operating Efficiency of Formosa Laboratories Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Formosa Laboratories Inc is operating .

  • Measures how much profit Formosa Laboratories Inc makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Formosa Laboratories Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Formosa Laboratories Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.6%-3.6%
TTM-5Y6.8%-6.8%
5Y6.8%10Y5.6%+1.2%
1.2.2. Operating Ratio

Measures how efficient Formosa Laboratories Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are NT$1.37 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Formosa Laboratories Inc:

  • The MRQ is 1.371. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.412. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.371TTM1.412-0.041
TTM1.412YOY1.592-0.180
TTM1.4125Y1.627-0.215
5Y1.62710Y1.305+0.322

1.3. Liquidity of Formosa Laboratories Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Formosa Laboratories Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.62 means the company has NT$1.62 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Formosa Laboratories Inc:

  • The MRQ is 1.618. The company is able to pay all its short-term debts. +1
  • The TTM is 1.570. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.618TTM1.570+0.048
TTM1.570YOY1.408+0.162
TTM1.5705Y1.410+0.159
5Y1.41010Y1.003+0.407
1.3.2. Quick Ratio

Measures if Formosa Laboratories Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Formosa Laboratories Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.60 means the company can pay off NT$0.60 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Formosa Laboratories Inc:

  • The MRQ is 0.600. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.481. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.600TTM0.481+0.119
TTM0.481YOY0.439+0.042
TTM0.4815Y0.427+0.053
5Y0.42710Y0.437-0.010

1.4. Solvency of Formosa Laboratories Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Formosa Laboratories Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Formosa Laboratories Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.40 means that Formosa Laboratories Inc assets are financed with 39.8% credit (debt) and the remaining percentage (100% - 39.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Formosa Laboratories Inc:

  • The MRQ is 0.398. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.392. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.398TTM0.392+0.006
TTM0.392YOY0.385+0.006
TTM0.3925Y0.434-0.042
5Y0.43410Y0.443-0.009
1.4.2. Debt to Equity Ratio

Measures if Formosa Laboratories Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Formosa Laboratories Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 71.7% means that company has NT$0.72 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Formosa Laboratories Inc:

  • The MRQ is 0.717. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.694. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.717TTM0.694+0.022
TTM0.694YOY0.646+0.048
TTM0.6945Y0.820-0.125
5Y0.82010Y0.828-0.008

2. Market Valuation of Formosa Laboratories Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Formosa Laboratories Inc generates.

  • Above 15 is considered overpriced but always compare Formosa Laboratories Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 16.80 means the investor is paying NT$16.80 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Formosa Laboratories Inc:

  • The EOD is 17.701. Based on the earnings, the company is fair priced.
  • The MRQ is 16.795. Based on the earnings, the company is fair priced.
  • The TTM is -16.136. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD17.701MRQ16.795+0.906
MRQ16.795TTM-16.136+32.932
TTM-16.136YOY-43.107+26.971
TTM-16.1365Y-11.603-4.534
5Y-11.60310Y11.507-23.110
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Formosa Laboratories Inc:

  • The EOD is 14.679. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.928. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 101.396. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD14.679MRQ13.928+0.751
MRQ13.928TTM101.396-87.468
TTM101.396YOY-11.392+112.788
TTM101.3965Y14.712+86.684
5Y14.71210Y5.340+9.372
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Formosa Laboratories Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.49 means the investor is paying NT$1.49 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Formosa Laboratories Inc:

  • The EOD is 1.575. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.494. Based on the equity, the company is underpriced. +1
  • The TTM is 1.336. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.575MRQ1.494+0.081
MRQ1.494TTM1.336+0.158
TTM1.336YOY0.938+0.398
TTM1.3365Y1.089+0.246
5Y1.08910Y1.778-0.689
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Formosa Laboratories Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.1610.861+35%0.404+188%1.519-24%1.184-2%
Book Value Per Share--68.27367.051+2%61.074+12%54.299+26%42.183+62%
Current Ratio--1.6181.570+3%1.408+15%1.410+15%1.003+61%
Debt To Asset Ratio--0.3980.392+2%0.385+3%0.434-8%0.443-10%
Debt To Equity Ratio--0.7170.694+3%0.646+11%0.820-13%0.828-13%
Dividend Per Share----0%1.500-100%0.462-100%0.723-100%
Eps--1.5180.262+479%0.851+78%0.913+66%0.757+101%
Free Cash Flow Per Share--1.8310.595+208%0.422+334%-0.574+131%-0.431+124%
Free Cash Flow To Equity Per Share--1.8310.595+208%1.353+35%0.166+1003%0.751+144%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--127.577--------
Intrinsic Value_10Y_min--73.118--------
Intrinsic Value_1Y_max--2.533--------
Intrinsic Value_1Y_min---0.186--------
Intrinsic Value_3Y_max--15.424--------
Intrinsic Value_3Y_min--5.944--------
Intrinsic Value_5Y_max--37.733--------
Intrinsic Value_5Y_min--19.156--------
Market Cap12927520000.000+5%12266112000.00010786963200.000+14%6905700800.000+78%7180816464.000+71%7925780737.920+55%
Net Profit Margin--0.1510.025+509%0.074+103%0.122+24%0.113+33%
Operating Margin----0%0.036-100%0.068-100%0.056-100%
Operating Ratio--1.3711.412-3%1.592-14%1.627-16%1.305+5%
Pb Ratio1.575+5%1.4941.336+12%0.938+59%1.089+37%1.778-16%
Pe Ratio17.701+5%16.795-16.136+196%-43.107+357%-11.603+169%11.507+46%
Price Per Share107.500+5%102.00089.700+14%57.425+78%59.713+71%65.908+55%
Price To Free Cash Flow Ratio14.679+5%13.928101.396-86%-11.392+182%14.712-5%5.340+161%
Price To Total Gains Ratio92.592+5%87.855-21.363+124%-30.921+135%0.313+27960%27.397+221%
Quick Ratio--0.6000.481+25%0.439+37%0.427+40%0.437+37%
Return On Assets--0.0130.002+500%0.007+80%0.009+50%0.010+33%
Return On Equity--0.0240.004+490%0.013+83%0.016+47%0.018+31%
Total Gains Per Share--1.1610.861+35%1.904-39%1.980-41%1.907-39%
Usd Book Value--254516231.000249960192.000+2%227679469.000+12%202424799.750+26%157254002.250+62%
Usd Book Value Change Per Share--0.0360.027+35%0.013+188%0.047-24%0.037-2%
Usd Book Value Per Share--2.1162.079+2%1.893+12%1.683+26%1.308+62%
Usd Dividend Per Share----0%0.046-100%0.014-100%0.022-100%
Usd Eps--0.0470.008+479%0.026+78%0.028+66%0.023+101%
Usd Free Cash Flow--6825239.0002217228.500+208%1574056.000+334%-2140582.550+131%-1605143.575+124%
Usd Free Cash Flow Per Share--0.0570.018+208%0.013+334%-0.018+131%-0.013+124%
Usd Free Cash Flow To Equity Per Share--0.0570.018+208%0.042+35%0.005+1003%0.023+144%
Usd Market Cap400753120.000+5%380249472.000334395859.200+14%214076724.800+78%222605310.384+71%245699202.876+55%
Usd Price Per Share3.333+5%3.1622.781+14%1.780+78%1.851+71%2.043+55%
Usd Profit--5660073.000978383.250+479%3172532.250+78%3404362.650+66%2821121.675+101%
Usd Revenue--37581889.00033793472.000+11%29182656.000+29%26510279.300+42%23724932.400+58%
Usd Total Gains Per Share--0.0360.027+35%0.059-39%0.061-41%0.059-39%
 EOD+4 -4MRQTTM+27 -5YOY+24 -115Y+25 -1010Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of Formosa Laboratories Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.701
Price to Book Ratio (EOD)Between0-11.575
Net Profit Margin (MRQ)Greater than00.151
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.600
Current Ratio (MRQ)Greater than11.618
Debt to Asset Ratio (MRQ)Less than10.398
Debt to Equity Ratio (MRQ)Less than10.717
Return on Equity (MRQ)Greater than0.150.024
Return on Assets (MRQ)Greater than0.050.013
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Formosa Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.065
Ma 20Greater thanMa 50107.515
Ma 50Greater thanMa 100107.940
Ma 100Greater thanMa 200104.467
OpenGreater thanClose110.500
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets13,636,191
Total Liabilities5,425,990
Total Stockholder Equity7,570,952
 As reported
Total Liabilities 5,425,990
Total Stockholder Equity+ 7,570,952
Total Assets = 13,636,191

Assets

Total Assets13,636,191
Total Current Assets5,243,666
Long-term Assets8,392,525
Total Current Assets
Cash And Cash Equivalents 1,526,013
Short-term Investments 984,475
Net Receivables 960,009
Inventory 1,597,467
Other Current Assets 2,015
Total Current Assets  (as reported)5,243,666
Total Current Assets  (calculated)5,069,979
+/- 173,687
Long-term Assets
Property Plant Equipment 6,067,676
Long-term Assets Other 85,421
Long-term Assets  (as reported)8,392,525
Long-term Assets  (calculated)6,153,097
+/- 2,239,428

Liabilities & Shareholders' Equity

Total Current Liabilities3,241,391
Long-term Liabilities2,184,599
Total Stockholder Equity7,570,952
Total Current Liabilities
Short Long Term Debt 1,983,760
Accounts payable 202,109
Other Current Liabilities 102,792
Total Current Liabilities  (as reported)3,241,391
Total Current Liabilities  (calculated)2,288,661
+/- 952,730
Long-term Liabilities
Long term Debt 2,037,897
Capital Lease Obligations Min Short Term Debt42,749
Long-term Liabilities Other 23,371
Long-term Liabilities  (as reported)2,184,599
Long-term Liabilities  (calculated)2,104,017
+/- 80,582
Total Stockholder Equity
Retained Earnings 2,269,213
Total Stockholder Equity (as reported)7,570,952
Total Stockholder Equity (calculated)2,269,213
+/- 5,301,739
Other
Capital Stock1,202,560
Common Stock Shares Outstanding 120,256
Net Debt 2,495,644
Net Invested Capital 11,592,609
Net Working Capital 2,002,275
Property Plant and Equipment Gross 6,067,676



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-30
> Total Assets 
2,189,833
2,338,117
2,375,261
2,435,786
2,536,394
2,852,146
3,113,429
3,302,044
3,526,319
3,744,733
4,035,567
3,991,045
4,415,204
4,882,312
4,990,983
4,891,175
5,046,037
5,249,146
5,690,423
5,843,389
5,804,394
5,895,064
6,456,212
6,766,489
6,941,603
6,705,342
6,734,413
6,762,223
6,992,247
6,883,860
7,241,736
7,553,995
7,774,752
7,762,084
8,725,242
9,068,474
9,074,825
9,269,508
9,608,401
9,836,684
10,528,700
10,476,450
10,285,771
12,059,233
12,672,384
12,171,148
12,016,967
11,391,663
11,385,286
12,268,382
12,750,713
12,544,550
13,557,862
13,300,438
13,636,191
13,636,19113,300,43813,557,86212,544,55012,750,71312,268,38211,385,28611,391,66312,016,96712,171,14812,672,38412,059,23310,285,77110,476,45010,528,7009,836,6849,608,4019,269,5089,074,8259,068,4748,725,2427,762,0847,774,7527,553,9957,241,7366,883,8606,992,2476,762,2236,734,4136,705,3426,941,6036,766,4896,456,2125,895,0645,804,3945,843,3895,690,4235,249,1465,046,0374,891,1754,990,9834,882,3124,415,2043,991,0454,035,5673,744,7333,526,3193,302,0443,113,4292,852,1462,536,3942,435,7862,375,2612,338,1172,189,833
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,242,953
2,192,024
2,521,966
2,287,414
2,479,843
2,483,336
2,553,249
2,531,843
3,227,958
3,051,638
2,924,605
2,838,923
2,748,693
2,923,746
3,236,707
3,106,133
3,148,251
3,911,666
3,600,304
3,457,015
3,619,490
3,309,993
3,359,027
3,926,906
4,151,060
4,061,490
5,095,624
5,040,220
5,243,666
5,243,6665,040,2205,095,6244,061,4904,151,0603,926,9063,359,0273,309,9933,619,4903,457,0153,600,3043,911,6663,148,2513,106,1333,236,7072,923,7462,748,6932,838,9232,924,6053,051,6383,227,9582,531,8432,553,2492,483,3362,479,8432,287,4142,521,9662,192,0242,242,95300000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
347,475
572,572
705,739
556,719
618,508
515,820
433,440
446,030
871,606
740,358
677,287
511,397
453,772
682,128
574,237
678,913
581,009
1,195,174
899,640
846,953
729,535
601,931
598,215
950,910
1,279,462
1,353,413
1,948,308
1,235,959
1,526,013
1,526,0131,235,9591,948,3081,353,4131,279,462950,910598,215601,931729,535846,953899,6401,195,174581,009678,913574,237682,128453,772511,397677,287740,358871,606446,030433,440515,820618,508556,719705,739572,572347,47500000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,754
26,529
29,126
26,087
20,000
305,605
271,141
231,224
347,229
296,762
270,979
363,946
237,096
230,966
374,576
351,069
181,357
175,826
988,208
984,475
984,475988,208175,826181,357351,069374,576230,966237,096363,946270,979296,762347,229231,224271,141305,60520,00026,08729,12626,52915,75400000000000000000000000000000000000
       Net Receivables 
661,867
708,322
631,192
603,644
587,061
743,204
780,844
615,688
723,635
614,399
704,563
286,417
787,284
763,747
818,152
839,766
814,994
680,045
713,409
668,267
710,362
792,124
941,508
790,861
926,017
779,812
887,396
553,646
722,051
684,142
849,478
785,008
929,392
856,539
895,821
828,067
773,252
855,564
906,537
787,581
868,663
704,509
784,802
728,480
718,334
657,648
803,193
798,347
803,747
953,937
827,127
772,908
953,340
966,979
960,009
960,009966,979953,340772,908827,127953,937803,747798,347803,193657,648718,334728,480784,802704,509868,663787,581906,537855,564773,252828,067895,821856,539929,392785,008849,478684,142722,051553,646887,396779,812926,017790,861941,508792,124710,362668,267713,409680,045814,994839,766818,152763,747787,284286,417704,563614,399723,635615,688780,844743,204587,061603,644631,192708,322661,867
       Other Current Assets 
47,949
44,521
45,138
62,340
57,698
94,389
87,494
75,148
81,303
99,793
57,942
55,291
84,329
72,919
63,226
65,367
68,817
98,404
60,256
47,427
51,019
59,552
89,835
81,703
85,474
89,475
75,652
56,803
75,918
96,949
98,571
111,610
9,603
7,102
4,320
4,927
4,783
5,162
4,654
4,935
3,384
5,694
6,753
16,330
10,166
5,570
3,810
2,202
2,349
3,440
2,242
5,747
7,249
13,567
2,015
2,01513,5677,2495,7472,2423,4402,3492,2023,8105,57010,16616,3306,7535,6943,3844,9354,6545,1624,7834,9274,3207,1029,603111,61098,57196,94975,91856,80375,65289,47585,47481,70389,83559,55251,01947,42760,25698,40468,81765,36763,22672,91984,32955,29157,94299,79381,30375,14887,49494,38957,69862,34045,13844,52147,949
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,016,836
6,150,220
6,430,585
6,859,708
6,912,938
7,291,993
7,370,317
7,137,520
8,147,567
9,072,080
8,714,133
8,397,477
8,081,670
8,026,259
8,341,476
8,599,653
8,483,060
8,462,238
8,260,218
8,392,525
8,392,5258,260,2188,462,2388,483,0608,599,6538,341,4768,026,2598,081,6708,397,4778,714,1339,072,0808,147,5677,137,5207,370,3177,291,9936,912,9386,859,7086,430,5856,150,2206,016,83600000000000000000000000000000000000
       Property Plant Equipment 
1,000,503
1,076,679
1,095,993
1,126,590
1,177,706
1,299,799
1,436,586
1,542,356
1,658,612
1,724,658
1,842,041
2,233,935
2,343,547
2,498,132
2,673,403
2,697,569
2,765,982
2,813,160
2,928,613
2,989,567
2,992,071
2,993,708
3,012,247
3,041,063
3,114,489
3,220,132
3,273,620
3,291,844
3,368,721
3,455,633
3,572,919
3,633,380
3,679,633
3,714,020
3,909,446
4,348,865
4,565,885
4,756,247
5,495,403
5,603,271
5,719,962
5,709,018
5,800,617
5,818,893
5,793,523
5,803,022
5,900,687
5,948,225
5,934,977
5,936,863
5,918,581
5,945,021
6,011,810
6,061,891
6,067,676
6,067,6766,061,8916,011,8105,945,0215,918,5815,936,8635,934,9775,948,2255,900,6875,803,0225,793,5235,818,8935,800,6175,709,0185,719,9625,603,2715,495,4034,756,2474,565,8854,348,8653,909,4463,714,0203,679,6333,633,3803,572,9193,455,6333,368,7213,291,8443,273,6203,220,1323,114,4893,041,0633,012,2472,993,7082,992,0712,989,5672,928,6132,813,1602,765,9822,697,5692,673,4032,498,1322,343,5472,233,9351,842,0411,724,6581,658,6121,542,3561,436,5861,299,7991,177,7061,126,5901,095,9931,076,6791,000,503
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
82,167
82,167
82,167
82,167
82,167
82,167
82,167
82,167
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000082,16782,16782,16782,16782,16782,16782,16782,167000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,133,411
1,168,046
1,004,829
777,415
741,934
929,688
900,812
772,909
829,681
921,686
820,330
898,779
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000898,779820,330921,686829,681772,909900,812929,688741,934777,4151,004,8291,168,0461,133,41100000000000000000000000000
       Intangible Assets 
2,571
2,571
3,283
3,283
3,283
3,283
6,448
6,448
6,448
6,448
5,805
0
8,655
8,773
9,036
8,484
13,429
13,568
16,941
16,398
19,430
18,074
21,943
20,392
20,221
22,393
24,042
23,314
21,498
282,422
342,657
346,400
274,826
267,971
269,189
266,749
253,716
247,703
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000247,703253,716266,749269,189267,971274,826346,400342,657282,42221,49823,31424,04222,39320,22120,39221,94318,07419,43016,39816,94113,56813,4298,4849,0368,7738,65505,8056,4486,4486,4486,4483,2833,2833,2833,2832,5712,571
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
306,805
333,443
358,363
162,220
181,040
218,338
261,601
132,916
146,066
176,382
196,632
93,430
72,491
59,093
57,460
106,499
50,723
48,870
29,628
85,421
85,42129,62848,87050,723106,49957,46059,09372,49193,430196,632176,382146,066132,916261,601218,338181,040162,220358,363333,443306,80500000000000000000000000000000000000
> Total Liabilities 
914,375
994,394
981,916
500,300
789,852
1,025,952
1,233,595
1,398,440
1,834,003
2,072,890
2,361,278
2,483,532
2,905,536
2,588,417
2,475,306
2,307,182
2,388,364
2,416,598
2,655,194
2,793,641
2,933,592
2,886,734
2,994,006
3,065,218
3,258,491
2,789,238
2,630,824
2,578,317
3,041,530
2,912,613
3,140,900
3,292,301
3,682,337
3,473,577
4,167,424
4,496,927
4,688,780
4,721,748
5,151,113
5,262,820
5,174,479
5,033,962
5,000,054
5,215,062
4,561,452
4,381,625
4,414,802
4,242,844
4,521,402
4,699,362
4,954,440
4,817,011
5,313,257
5,229,855
5,425,990
5,425,9905,229,8555,313,2574,817,0114,954,4404,699,3624,521,4024,242,8444,414,8024,381,6254,561,4525,215,0625,000,0545,033,9625,174,4795,262,8205,151,1134,721,7484,688,7804,496,9274,167,4243,473,5773,682,3373,292,3013,140,9002,912,6133,041,5302,578,3172,630,8242,789,2383,258,4913,065,2182,994,0062,886,7342,933,5922,793,6412,655,1942,416,5982,388,3642,307,1822,475,3062,588,4172,905,5362,483,5322,361,2782,072,8901,834,0031,398,4401,233,5951,025,952789,852500,300981,916994,394914,375
   > Total Current Liabilities 
763,670
843,690
830,713
414,905
720,613
921,686
1,213,982
1,308,633
1,483,995
1,582,818
1,401,709
1,547,574
1,701,573
1,594,119
1,771,535
1,573,809
1,660,599
1,260,343
1,468,944
1,721,177
1,687,812
1,538,033
1,892,696
1,717,242
2,036,751
2,036,599
1,931,441
1,932,316
2,492,270
2,199,647
2,283,606
2,267,571
2,427,117
1,301,045
1,353,987
1,579,424
1,798,715
1,975,189
2,473,428
2,900,688
2,640,293
3,476,040
3,039,987
3,101,416
2,339,220
2,020,502
2,385,790
2,268,568
2,444,137
2,658,677
3,141,649
2,852,883
3,171,446
3,089,762
3,241,391
3,241,3913,089,7623,171,4462,852,8833,141,6492,658,6772,444,1372,268,5682,385,7902,020,5022,339,2203,101,4163,039,9873,476,0402,640,2932,900,6882,473,4281,975,1891,798,7151,579,4241,353,9871,301,0452,427,1172,267,5712,283,6062,199,6472,492,2701,932,3161,931,4412,036,5992,036,7511,717,2421,892,6961,538,0331,687,8121,721,1771,468,9441,260,3431,660,5991,573,8091,771,5351,594,1191,701,5731,547,5741,401,7091,582,8181,483,9951,308,6331,213,982921,686720,613414,905830,713843,690763,670
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,855,526
1,972,523
2,172,234
784,404
983,830
1,657,847
513,554
277,238
243,343
604,432
761,702
948,934
1,114,257
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,114,257948,934761,702604,432243,343277,238513,5541,657,847983,830784,4042,172,2341,972,5231,855,52600000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,855,526
1,972,523
2,172,234
784,404
983,830
1,657,847
513,554
277,238
243,343
604,432
761,702
948,934
1,114,257
1,334,779
1,313,100
1,346,585
1,267,965
1,302,247
1,119,468
919,098
1,178,963
1,109,400
1,084,063
1,720,787
2,119,609
1,848,978
1,889,815
1,883,696
1,983,760
1,983,7601,883,6961,889,8151,848,9782,119,6091,720,7871,084,0631,109,4001,178,963919,0981,119,4681,302,2471,267,9651,346,5851,313,1001,334,7791,114,257948,934761,702604,432243,343277,238513,5541,657,847983,830784,4042,172,2341,972,5231,855,52600000000000000000000000000
       Accounts payable 
63,321
75,073
156,662
111,660
81,894
74,434
60,313
104,532
101,755
93,741
109,373
83,757
109,824
142,944
173,777
178,601
129,343
97,302
132,523
112,355
129,515
152,063
182,083
97,874
139,369
82,872
196,992
104,737
122,959
93,451
162,961
177,793
161,681
186,157
230,155
116,557
106,740
133,549
267,921
278,791
131,250
143,451
208,138
116,607
110,209
92,357
204,054
139,863
161,568
164,325
187,490
154,595
204,220
193,003
202,109
202,109193,003204,220154,595187,490164,325161,568139,863204,05492,357110,209116,607208,138143,451131,250278,791267,921133,549106,740116,557230,155186,157161,681177,793162,96193,451122,959104,737196,99282,872139,36997,874182,083152,063129,515112,355132,52397,302129,343178,601173,777142,944109,82483,757109,37393,741101,755104,53260,31374,43481,894111,660156,66275,07363,321
       Other Current Liabilities 
473,807
259,156
206,304
174,755
454,361
232,542
289,635
286,125
536,372
363,423
312,521
241,978
305,903
326,896
372,643
311,803
345,840
335,556
377,563
353,752
484,314
319,667
401,821
413,494
667,952
534,902
550,476
474,875
720,152
483,363
557,874
1,180,674
380,909
208,957
265,112
251,138
259,081
352,258
341,562
308,110
278,640
204,748
261,394
368,235
257,376
338,023
297,623
291,638
582,914
392,499
31,700
469,759
76,678
69,125
102,792
102,79269,12576,678469,75931,700392,499582,914291,638297,623338,023257,376368,235261,394204,748278,640308,110341,562352,258259,081251,138265,112208,957380,9091,180,674557,874483,363720,152474,875550,476534,902667,952413,494401,821319,667484,314353,752377,563335,556345,840311,803372,643326,896305,903241,978312,521363,423536,372286,125289,635232,542454,361174,755206,304259,156473,807
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,917,503
2,890,065
2,746,559
2,677,685
2,362,132
2,534,186
1,557,922
1,960,067
2,113,646
2,222,232
2,361,123
2,029,012
1,974,276
2,077,265
2,040,685
1,812,791
1,964,128
2,141,811
2,140,093
2,184,599
2,184,5992,140,0932,141,8111,964,1281,812,7912,040,6852,077,2651,974,2762,029,0122,361,1232,222,2322,113,6461,960,0671,557,9222,534,1862,362,1322,677,6852,746,5592,890,0652,917,50300000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,855,526
-1,972,523
-2,172,234
-784,404
-983,830
-1,657,847
-513,554
-277,238
-243,343
-522,018
-680,013
-870,906
-1,035,070
71,468
67,922
58,513
49,348
49,155
53,395
49,139
51,239
46,667
40,626
35,814
43,529
37,424
37,274
35,846
42,749
42,74935,84637,27437,42443,52935,81440,62646,66751,23949,13953,39549,15549,34858,51367,92271,468-1,035,070-870,906-680,013-522,018-243,343-277,238-513,554-1,657,847-983,830-784,404-2,172,234-1,972,523-1,855,52600000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
112,750
113,518
114,345
110,789
112,832
108,330
104,079
67,430
66,935
61,494
60,921
74,572
48,765
50,022
52,251
50,556
16,849
16,849
16,848
23,371
23,37116,84816,84916,84950,55652,25150,02248,76574,57260,92161,49466,93567,430104,079108,330112,832110,789114,345113,518112,75000000000000000000000000000000000000
> Total Stockholder Equity
1,275,458
1,343,723
1,393,345
1,935,486
1,746,542
1,826,194
1,879,834
1,903,604
1,692,316
1,671,843
1,674,289
1,507,513
1,509,668
2,293,895
2,515,677
2,583,993
2,657,673
2,832,548
3,035,229
3,049,748
2,870,802
3,008,330
3,462,206
3,701,271
3,683,112
3,916,104
4,103,589
4,183,906
3,950,717
3,971,247
4,019,395
4,189,861
4,031,986
4,237,099
4,407,357
4,438,977
4,269,347
4,440,983
4,361,782
4,358,621
5,230,637
5,335,927
5,205,073
6,458,413
7,781,759
7,511,567
7,395,230
6,996,532
6,748,399
7,243,952
7,520,644
7,496,020
7,494,320
7,376,121
7,570,952
7,570,9527,376,1217,494,3207,496,0207,520,6447,243,9526,748,3996,996,5327,395,2307,511,5677,781,7596,458,4135,205,0735,335,9275,230,6374,358,6214,361,7824,440,9834,269,3474,438,9774,407,3574,237,0994,031,9864,189,8614,019,3953,971,2473,950,7174,183,9064,103,5893,916,1043,683,1123,701,2713,462,2063,008,3302,870,8023,049,7483,035,2292,832,5482,657,6732,583,9932,515,6772,293,8951,509,6681,507,5131,674,2891,671,8431,692,3161,903,6041,879,8341,826,1941,746,5421,935,4861,393,3451,343,7231,275,458
   Common Stock
609,320
609,320
609,320
670,570
670,570
670,570
670,570
670,570
670,570
670,570
670,570
672,645
672,686
806,316
840,589
843,349
844,095
844,116
844,116
851,378
851,378
853,537
874,682
874,682
874,682
886,331
887,167
892,286
899,227
930,126
930,126
930,126
930,126
990,126
990,126
990,126
990,126
990,126
990,126
990,126
1,083,126
1,083,126
1,083,126
1,083,126
1,083,639
1,202,560
1,202,560
1,202,560
1,202,560
1,202,560
1,202,560
0
0
0
0
00001,202,5601,202,5601,202,5601,202,5601,202,5601,202,5601,083,6391,083,1261,083,1261,083,1261,083,126990,126990,126990,126990,126990,126990,126990,126930,126930,126930,126930,126899,227892,286887,167886,331874,682874,682874,682853,537851,378851,378844,116844,116844,095843,349840,589806,316672,686672,645670,570670,570670,570670,570670,570670,570670,570670,570609,320609,320609,320
   Retained Earnings 
228,522
296,787
346,409
413,726
200,120
264,416
318,114
341,935
107,514
87,098
65,310
36,260
38,380
82,823
129,656
185,465
244,222
333,508
391,320
432,880
280,686
394,396
508,187
612,371
583,398
679,675
813,574
864,981
716,991
755,956
782,677
1,212,887
1,054,126
929,780
1,031,356
801,997
615,867
787,656
991,670
889,790
1,423,963
1,524,857
1,389,585
2,455,397
3,200,026
2,815,463
2,640,027
2,239,673
1,990,628
2,482,710
2,809,299
2,339,138
2,206,315
2,091,761
2,269,213
2,269,2132,091,7612,206,3152,339,1382,809,2992,482,7101,990,6282,239,6732,640,0272,815,4633,200,0262,455,3971,389,5851,524,8571,423,963889,790991,670787,656615,867801,9971,031,356929,7801,054,1261,212,887782,677755,956716,991864,981813,574679,675583,398612,371508,187394,396280,686432,880391,320333,508244,222185,465129,65682,82338,38036,26065,31087,098107,514341,935318,114264,416200,120413,726346,409296,787228,522
   Capital Surplus 0000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
724,680
709,285
535,823
301,320
256,776
-2,968
-2,082
-4,715
2,023
1,502
320
167
-3,866
94,726
-3,220
-3,508
-268
-6,220
91,096
-9,838
49,261
50,917
43,863
44,550
-5,703
-5,325
0
0
0
000-5,325-5,70344,55043,86350,91749,261-9,83891,096-6,220-268-3,508-3,22094,726-3,8661673201,5022,023-4,715-2,082-2,968256,776301,320535,823709,285724,68000000000000000000000000000



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,360,448
Cost of Revenue-2,437,119
Gross Profit1,923,3291,923,329
 
Operating Income (+$)
Gross Profit1,923,329
Operating Expense-3,711,936
Operating Income648,512-1,788,607
 
Operating Expense (+$)
Research Development841,872
Selling General Administrative432,945
Selling And Marketing Expenses0
Operating Expense3,711,9361,274,817
 
Net Interest Income (+$)
Interest Income23,708
Interest Expense-34,735
Other Finance Cost-0
Net Interest Income-11,027
 
Pretax Income (+$)
Operating Income648,512
Net Interest Income-11,027
Other Non-Operating Income Expenses0
Income Before Tax (EBT)142,391648,512
EBIT - interestExpense = -34,735
126,243
160,978
Interest Expense34,735
Earnings Before Interest and Taxes (EBIT)0177,126
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax142,391
Tax Provision-194,650
Net Income From Continuing Ops-52,259-52,259
Net Income126,243
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net011,027
 

Technical Analysis of Formosa Laboratories Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Formosa Laboratories Inc. The general trend of Formosa Laboratories Inc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Formosa Laboratories Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Formosa Laboratories Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 117.00 < 121.00 < 121.00.

The bearish price targets are: 105.00 > 105.00 > 96.80.

Tweet this
Formosa Laboratories Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Formosa Laboratories Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Formosa Laboratories Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Formosa Laboratories Inc. The current macd is 1.69929046.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Formosa Laboratories Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Formosa Laboratories Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Formosa Laboratories Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Formosa Laboratories Inc Daily Moving Average Convergence/Divergence (MACD) ChartFormosa Laboratories Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Formosa Laboratories Inc. The current adx is 20.56.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Formosa Laboratories Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Formosa Laboratories Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Formosa Laboratories Inc. The current sar is 121.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Formosa Laboratories Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Formosa Laboratories Inc. The current rsi is 49.06. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Formosa Laboratories Inc Daily Relative Strength Index (RSI) ChartFormosa Laboratories Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Formosa Laboratories Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Formosa Laboratories Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Formosa Laboratories Inc Daily Stochastic Oscillator ChartFormosa Laboratories Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Formosa Laboratories Inc. The current cci is 8.1365398.

Formosa Laboratories Inc Daily Commodity Channel Index (CCI) ChartFormosa Laboratories Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Formosa Laboratories Inc. The current cmo is -6.76840353.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Formosa Laboratories Inc Daily Chande Momentum Oscillator (CMO) ChartFormosa Laboratories Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Formosa Laboratories Inc. The current willr is -75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Formosa Laboratories Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Formosa Laboratories Inc Daily Williams %R ChartFormosa Laboratories Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Formosa Laboratories Inc.

Formosa Laboratories Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Formosa Laboratories Inc. The current atr is 5.3531808.

Formosa Laboratories Inc Daily Average True Range (ATR) ChartFormosa Laboratories Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Formosa Laboratories Inc. The current obv is 206,254,135.

Formosa Laboratories Inc Daily On-Balance Volume (OBV) ChartFormosa Laboratories Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Formosa Laboratories Inc. The current mfi is 54.46.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Formosa Laboratories Inc Daily Money Flow Index (MFI) ChartFormosa Laboratories Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Formosa Laboratories Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Formosa Laboratories Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Formosa Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.065
Ma 20Greater thanMa 50107.515
Ma 50Greater thanMa 100107.940
Ma 100Greater thanMa 200104.467
OpenGreater thanClose110.500
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Formosa Laboratories Inc with someone you think should read this too:
  • Are you bullish or bearish on Formosa Laboratories Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Formosa Laboratories Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Formosa Laboratories Inc

I send you an email if I find something interesting about Formosa Laboratories Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Formosa Laboratories Inc.

Receive notifications about Formosa Laboratories Inc in your mailbox!